Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rajendra Makkar

Interventional Cardiology West Hollywood, CA Medical Doctor

NPI 1164450235 CMS profile 189090

8700 Beverly Blvd, West Hollywood, CA 90048

Open in the dashboard

General payments

$122,505

659 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$12,000

1 holding reported · through program year 2025

Research they led as principal investigator

$16,438,610 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Rajendra Makkar of West Hollywood, CA is reported in the CMS Open Payments database as having received $122,505 across 659 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $16,438,610 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $12,000 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,378 100
2024 General $12,497 88
2023 General $19,310 80
2022 General $7,354 70
2021 General $6,777 88
2020 General $6,687 83
2019 General $40,501 150
2025 Ownership $12,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rajendra Makkar
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Rajendra Makkar were reported at $29,378. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Rajendra Makkar Interventional Cardiology median Middle half National median
2019 $40,501 $1,097 $329–$3,048 $163
2020 $6,687 $473 $161–$1,480 $114
2021 $6,777 $677 $233–$1,827 $132
2022 $7,354 $978 $333–$2,724 $149
2023 $19,310 $1,136 $382–$2,986 $160
2024 $12,497 $1,181 $395–$3,326 $164
2025 $29,378 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $71,038 458 payments
  2. Boston Scientific Corporation $27,535 69 payments
  3. Abbott Laboratories $8,133 80 payments
  4. Medtronic Vascular, Inc. $5,222 10 payments
  5. Daiichi Sankyo Inc. $4,334 1 payment
  6. JenaValve Technology, Inc. $2,115 8 payments
  7. Medtronic, Inc. $1,396 8 payments
  8. CathWorks, Inc. $585 2 payments
  9. Pi-Cardia, Inc. $499 3 payments
  10. Abiomed $413 5 payments
  11. Other $1,235 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $84,514 131 payments
  2. Food and Beverage $35,492 521 payments
  3. Consulting Fee $1,860 4 payments
  4. Honoraria $500 1 payment
  5. Education $84 1 payment
  6. Grant $55 1 payment
Products named General payments · program years 2019–2025
  1. Edwards SAPIEN 3 Transcatheter Heart Valve $12,267 38 payments
  2. SAPIEN 3 Ultra RESILIA $9,022 79 payments
  3. GENERAL THERAPIES $8,158 1 payment
  4. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $6,318 68 payments
  5. Savaysa $4,334 1 payment
  6. Mitra Clip system $3,417 31 payments
  7. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Transcatheter Heart Valves $2,427 42 payments
  8. PASCAL $2,090 33 payments
  9. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve Transcatheter Heart Valves $1,884 45 payments
  10. JenaValve Pericardial TAVR System $1,718 7 payments
  11. Other $9,316 130 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

33

Median for Interventional Cardiology: 2,236

Drug cost

$452

Median for Interventional Cardiology: $380,412

Branded share of claims

100%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 33 $452

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$823,485

Medicare's payments for the services billed

Medicare patients

999

Average age 79

Services billed

1,966

393 women, 606 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 70%
Arthritis 52%
Diabetes 46%
Atrial fibrillation 42%
Chronic kidney disease 37%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

659 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record